REVVITY, INC. reported first quarter ended April 5, 2026 results: revenue $711 million, EPS $0.37.
“OR IMMEDIATE RELEASE May 5, 2026 Revvity Announces Financial Results for the First Quarter of 2026 • Revenue of $711 million; pro forma revenue of $687 million; 7% revenue growth; 3% organic gro wth; 6% pro forma organic growth • GAAP EPS from continuing operations of $0.37 ; adjusted EPS from continuing operations of $1.06 ; GAAP pro forma EPS from continuing operations of $0.40; pro forma adjusted EPS from continuing operations of $1.04 • Announces intention to divest China Immunodiagnostics business • Updates full year 2026 guidance WALTHAM, Mass.”
Governance Changes
REVVITY, INC.: Amended bylaws to allow shareholders owning 25% of common stock to call a special meeting (effective 2026-04-28).
“At the annual meeting of shareholders of Revvity, Inc. (the “Company”) held on April 28, 2026, the shareholders voted on and approved a proposal to amend the Company’s Amended and Restated By-laws (prior to such amendment and restatement, the “Prior By-laws”) to allow shareholders owning 25% of the Company’s stock to call a special meeting of shareholders (as amended and restated, the “Amended and Restated By-laws”) effective as of April 28, 2026.”
Earnings Releases
REVVITY, INC. reported first quarter ended March 31, 2024 results: revenue $650 million, EPS $0.21. Guidance reaffirmed.
“reference in such a filing. --- EX-99.1 (EX-99.1) --- FOR IMMEDIATE RELEASE April 29, 2024 Revvity Announces Financial Results for the First Quarter of 2024 • Revenue of $650 million; (4)% reported growth; (3)% organic growth • First quarter GAAP EPS of $0.21; Adjusted EPS from continuing operations of $0.98 • Reaffirms full year 2024 organic growth and”
Shareholder Votes
REVVITY, INC. shareholders approved Shareholder proposal to adopt a simple majority voting standard at the 2024-04-23 meeting.
“Proposal #4 – Shareholder proposal to adopt a simple majority voting standard. For Against Abstain Broker Non-Votes 98,737,249 3,439,994 629,839 4,412,668”
Shareholder Votes
REVVITY, INC. shareholders approved Advisory vote to approve executive compensation at the 2024-04-23 meeting.
“Proposal #3 – To approve, by non-binding advisory vote, the Company’s executive compensation. For Against Abstain Broker Non-Votes 97,992,794 4,439,860 374,428 4,412,668”
Shareholder Votes
REVVITY, INC. shareholders approved Ratification of selection of Deloitte & Touche LLP as independent registered public accounting firm for the current fiscal year at the 2024-04-23 meeting.
“Proposal #2 – To ratify the selection of Deloitte & Touche LLP as the Company’s independent public accounting firm for the current fiscal year. For Against Abstain Broker Non-Votes 100,434,538 6,710,376 74,836 0”
Shareholder Votes
REVVITY, INC. shareholders approved Election of ten nominees for director for terms of one year each at the 2024-04-23 meeting.
“Proposal #1 – To elect the following nominees as our directors for terms of one year each: Name Votes in Favor Votes Against Abstentions Broker Non-Votes Peter Barrett, PhD 98,617,347 4,120,162 69,573 4,412,668 Samuel R. Chapin 101,875,015 796,619 135,448 4,412,668 Michael A. Klobuchar 102,480,081 180,975 146,026 4,412,668 Michelle McMurray-Heath, MD, PhD 102,142,236 597,229 67,617 4,412,668 Alexis P. Michas 100,947,761 1,800,119 59,202 4,412,668 Prahlad R. Singh, PhD 102,298,878 438,353 69,851 4,412,668 Sophie V. Vandebroek, PhD 102,553,295 185,366 68,421 4,412,668 Michael Vounatsos 99,620,162 3,071,552 115,368 4,412,668 Frank Witney, PhD 98,711,364 4,027,568 68,150 4,412,668 Pascale Witz 101,924,209 812,393 70,480 4,412,668”
Sophie V. Vandebroek was elected as Director at REVVITY, INC..
“On January 25, 2024, the Board elected Michael A. Klobuchar and Sophie V. Vandebroek to serve on the Board, effective February 1, 2024.”
Michael A. Klobuchar was elected as Director at REVVITY, INC..
“On January 25, 2024, the Board elected Michael A. Klobuchar and Sophie V. Vandebroek to serve on the Board, effective February 1, 2024.”
Dr. Sylvie Grégoire departed as Director at REVVITY, INC..
“On January 25, 2024, Dr. Sylvie Grégoire, a member of the Board of Directors (the “Board”) of Revvity, Inc. (“Revvity” or the “Company”) notified the Company of her decision not to stand for re-election to the Board at the annual meeting of shareholders of the Company scheduled to occur on April 23, 2024.”
Earnings Releases
REVVITY, INC. reported fourth quarter ended December 31, 2023 results: revenue at least $690 million.
“Revenue for the fourth quarter is expected to be at least $690 million”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.